— We carried out an investigational study of early detection of prostate carcinoma, using digital rectal examination (DRE) and serum prostate specific antigen (PSA). We determined the detection rate and some profiles of the carcinoma detected by screening in men from 50 to 80 years old. The detection rate was 2.3% in 1345 participants. In 20 men (64.5%) the disease was T1c or T2 and in 16 patients we performed radical prostatectomy.
PaganiG., IannicelliP., RosaA., AimèG., CerartiG., CobianchiP.G.: Screening per la diagnosi precoce del carcinoma prostatico nell'Ossola: risultati dopo 1 anno di lavoro. Arch. It. Urol., 66: 47–50, 1994.
2.
JerrainoD., FranceshiS.: Epidemiological size of cancer problem in the elderly. NAM, 5: 12, 1989.
3.
LeviF., MaissoneuveP., FilibertiL., La VecchiaC., BoyleP.: Cancer incidence and mortality in Europe. Soziai und Präventiv Medizin, 2, suppl. 1, 1989.
4.
JacobiG.H., HohenfellnerR.: Prostate cancer. Baltimore Williams and Wilkins Co. Ed. 1982.
5.
ISTAT, Annuari di statistica sanitaria 1988.
6.
RichieJ.P., RatliffT.L., CatalonaW.J.: Effect of patient age on early detection of prostate cancer with serum prostate-specific antigen and digital rectal examination. Urology, 42 (4): 365–374, 1993.
7.
PavoneMacaluso M.: Early cancer e neoplasie prostatiche iniziali, con particolare riguardo al problema dello screening. In: Early Cancer in Urologia, Salvatore Rocca Rossetti. Archimedica, Torino, pp. 133–154, 1995.
8.
StoneN.N., DeAntoniE.P., CrawfordE.D.: Screening for prostate cancer by digital rectal examination and prostate specific antigen. Results of prostate cancer awareness week, 1989–1992. Urology, 44 (6A): 18–25, 1994.
9.
MinariR., CantoniC., BenecchiL., PieriI., SavinoA., PratiA., SacchiniP., PotenzoniD.: Risultati di uno screening di massa per il carcinoma prostatico. Urologia, 58 (5): 593–596, 1991.
10.
MettlinC.: The status of prostate cancer early detection. Cancer, 72 (3): 1050–1055, 1993.
11.
BrawerM.K., BeatieJ., WenerM.H., VessellaR.L., PrestonS.D., LangeP.H.: Screening for prostatic carcinoma with prostate specific antigen: results of the second year. J. Urol., 150: 106–109, 1993.
12.
BenoitR.M., NaslundM.J.: An economic rationale for prostate cancer screening. Urology, 44: 795–803, 1994.
VaglianiG., PerroneA., SalviG., MisurielloG., Di SilverioA., ValmoriV., MauceriG., CretiS., BatoumeniG., FiniM.: Impatto economico del cancro della prostata nel comprensorio dell'ULSS n. 23 di Imola. Urologia, 61 (suppl. 1): 51–56, 1994.
ZaridzeD.G., BoyleP.: Cancer of prostate: epidemiology and aetiology. Br. J. Urol., 59: 493, 1987.
17.
KramerB.S., BrownM.L., ProrokP.C., PotoskyA.L., GohaganJ.K.: Prostate carcinoma screening: What we know and what we need to know. Ann. Intern. Med., 119: 914–923, 1993.
18.
TsukamotoT., KumamotoY., MasumoriN., ItohN., MatsukawaM., TakahashiA., UmeharaT., TakagiY.: Mass screening for prostate carcinoma: a study in Hokkaido. Japan. Eur. Urol., 27: 177–181, 1995.
19.
FiniM., VaglianiG., PerroneA., SalviG., MisurielloG., Di SilverioA., BatoumeniG., MauceriG., CretiS., BicocchiG., TartoniP.: Alcuni riscontri epidemiologici sulla prevalenza dei sintomi disurici e dell'ipertrofia prostatica benigna in 7.303 ultracinquantenni residenti nel territorio imolese. Urologia, 61 (3): 169–178, 1994.
20.
AkzakiK., StemmermannG.N.: Comparative study of latent carcinoma of prostate among Japanese in Japan and Hawaii. JNCI, 50: 1137, 1973.
